Aquestive Therapeutics, Inc. (AQST) Appoints Richard Daly to Board

Aquestive Therapeutics appointed Rich Daly to its Board of Directors, effective Oct. 14, 2026. The board will have eight directors, seven independent.Material DetailsContext by AI AnalystAquestive is in a pre-commercial phase preparing for a potential FDA decision and launch of Anaphylm. A positive…